Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma

• Jia-Hong Chen,

  Affiliations Division of Hematology-Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

  ⨯
• Shun-Neng Hsu,

  Affiliation Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Tzu-Chuan Huang,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Yi-Ying Wu,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Chin Lin,

  Affiliations Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, School of Public Health, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Ping-Ying Chang,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Yeu-Chin Chen,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Ching-Liang Ho

  * E-mail: hochingliang@yahoo.com.tw

  Affiliation Division of Hematology-Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯